AdvanSource Biomaterials Corp. (ASNB) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for AdvanSource Biomaterials Corp.
Fiscal year is April-March. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 2.12M 1.67M 1.87M 2.2M 2.63M
Cost of Goods Sold (COGS) incl. D&A 1.36M 1.52M 897,000 813,000 1.01M
COGS excluding D&A 1.09M 1.28M 700,000 625,000 826,000
Depreciation & Amortization Expense 269,000 248,000 197,000 188,000 180,000
Depreciation 269,000 248,000 197,000 188,000 180,000
Amortization of Intangibles 0 0 0 0 0
Gross Income 761,000 143,000 969,000 1.38M 1.62M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 3.38M 3.23M 2.45M 2.05M 1.83M
Research & Development 657,000 734,000 605,000 444,000 394,000
Other SG&A 2.73M 2.49M 1.84M 1.61M 1.43M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 103,000 167,000 0 -
EBIT after Unusual Expense 0 (103,000) (167,000) 0 -
Non Operating Income/Expense (13,000) 0 0 0 45,000
Non-Operating Interest Income 6,000 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 0 0 165,000 340,000 359,000
Gross Interest Expense 0 0 165,000 340,000 359,000
Interest Capitalized 0 0 0 0 0
Pretax Income (2.63M) (3.19M) (1.81M) (1.01M) (521,000)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.63M) (3.19M) (1.81M) (1.01M) (521,000)
Minority Interest Expense 0 0 0 0 0
Net Income (2.63M) (3.19M) (1.81M) (1.01M) (521,000)
Extraordinaries & Discontinued Operations 942,000 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 942,000 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.69M) (3.19M) (1.81M) (1.01M) (521,000)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.63M) (3.19M) (1.81M) (1.01M) (521,000)
EPS (Basic) (0.12) (0.15) (0.08) (0.05) (0.02)
Basic Shares Outstanding 21.15M 21.31M 21.42M 21.49M 21.49M
EPS (Diluted) (0.12) (0.15) (0.08) (0.05) (0.02)
Diluted Shares Outstanding 21.15M 21.31M 21.42M 21.49M 21.49M
EBITDA (2.35M) (2.83M) (1.28M) (483,000) (27,000)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for AdvanSource Biomaterials Corp.
Fiscal year is April-March. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 2.12M 1.67M 1.87M 2.2M 2.63M
Cost of Goods Sold (COGS) incl. D&A 1.36M 1.52M 897,000 813,000 1.01M
COGS excluding D&A 1.09M 1.28M 700,000 625,000 826,000
Depreciation & Amortization Expense 269,000 248,000 197,000 188,000 180,000
Depreciation 269,000 248,000 197,000 188,000 180,000
Amortization of Intangibles 0 0 0 0 0
Gross Income 761,000 143,000 969,000 1.38M 1.62M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 3.38M 3.23M 2.45M 2.05M 1.83M
Research & Development 657,000 734,000 605,000 444,000 394,000
Other SG&A 2.73M 2.49M 1.84M 1.61M 1.43M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 103,000 167,000 0 -
EBIT after Unusual Expense 0 (103,000) (167,000) 0 -
Non Operating Income/Expense (13,000) 0 0 0 45,000
Non-Operating Interest Income 6,000 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 0 0 165,000 340,000 359,000
Gross Interest Expense 0 0 165,000 340,000 359,000
Interest Capitalized 0 0 0 0 0
Pretax Income (2.63M) (3.19M) (1.81M) (1.01M) (521,000)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.63M) (3.19M) (1.81M) (1.01M) (521,000)
Minority Interest Expense 0 0 0 0 0
Net Income (2.63M) (3.19M) (1.81M) (1.01M) (521,000)
Extraordinaries & Discontinued Operations 942,000 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 942,000 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.69M) (3.19M) (1.81M) (1.01M) (521,000)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.63M) (3.19M) (1.81M) (1.01M) (521,000)
EPS (Basic) (0.12) (0.15) (0.08) (0.05) (0.02)
Basic Shares Outstanding 21.15M 21.31M 21.42M 21.49M 21.49M
EPS (Diluted) (0.12) (0.15) (0.08) (0.05) (0.02)
Diluted Shares Outstanding 21.15M 21.31M 21.42M 21.49M 21.49M
EBITDA (2.35M) (2.83M) (1.28M) (483,000) (27,000)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
